Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
GOSS
$0.15
-9.45%
GOSS · Gossamer Bio, Inc.
$0.15
-0.02 (-9.45%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has concluded that these circumstances and the uncertainties associated with the Company's ability to obtain additional equity or debt financing on terms that are favorable to the Company, or at all, and otherwise succeed in its future operations raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$75.38M
Shares
488.85M
All earnings calls
Earnings call · FY2023 Q2
Gossamer Bio, Inc. Q2 FY2023 Earnings Call
Gossamer Bio, Inc. Q2 FY2023 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$0
Diluted EPS
-$0.45
Net income
-$42.50M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 8, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 8, 2023 · complete as-filed document